Cargando…
Molecular Aspects Concerning the Use of the SARS-CoV-2 Receptor Binding Domain as a Target for Preventive Vaccines
[Image: see text] The development of recombinant COVID-19 vaccines has resulted from scientific progress made at an unprecedented speed during 2020. The recombinant spike glycoprotein monomer, its trimer, and its recombinant receptor-binding domain (RBD) induce a potent anti-RBD neutralizing antibod...
Autores principales: | Valdes-Balbin, Yury, Santana-Mederos, Darielys, Paquet, Françoise, Fernandez, Sonsire, Climent, Yanet, Chiodo, Fabrizio, Rodríguez, Laura, Sanchez Ramirez, Belinda, Leon, Kalet, Hernandez, Tays, Castellanos-Serra, Lila, Garrido, Raine, Chen, Guang-Wu, Garcia-Rivera, Dagmar, Rivera, Daniel G., Verez-Bencomo, Vicente |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084267/ https://www.ncbi.nlm.nih.gov/pubmed/34075345 http://dx.doi.org/10.1021/acscentsci.1c00216 |
Ejemplares similares
-
Glycan Array Evaluation of Synthetic Epitopes between
the Capsular Polysaccharides from Streptococcus pneumoniae 19F and 19A
por: Morelli, Laura, et al.
Publicado: (2021) -
Repeat-dose and local tolerance toxicity of SARS-CoV-2 FINLAY-FR-02 vaccine candidate in Sprague Dawley rats
por: Oliva-Hernández, Reynaldo, et al.
Publicado: (2022) -
Multicomponent polysaccharide–protein bioconjugation in the development of antibacterial glycoconjugate vaccine candidates
por: Méndez, Yanira, et al.
Publicado: (2018) -
A COVID-19 vaccine candidate composed of the SARS-CoV-2 RBD dimer and Neisseria meningitidis outer membrane vesicles
por: Santana-Mederos, Darielys, et al.
Publicado: (2021) -
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adults
por: Toledo-Romani, María Eugenia, et al.
Publicado: (2022)